Why the study?
Does antibiotic prophylaxis prevent device infection in recipients of new or replacement pacemakers or implantable cardioverter-defibrillators?
Does antibiotic prophylaxis prevent device infection in recipients of new or replacement pacemakers or implantable cardioverter-defibrillators?
Antibiotic prophylaxis is effective in preventing device infections in patients receiving new or replacement pacemakers or ICDs.
Supports prophylaxis to curb device infections; observational data leaves open need for RCTs to confirm causality.
This study identified several factors of risk of device infection and confirmed the efficacy of antibiotic prophylaxis in recipients of new or replacement pacemakers or implantable cardioverter-defibrillators.
No takes yet. Share an insight, caveat, or question.
Klug et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: